15 results
8-K
EX-99.1
ARQT
Arcutis Biotherapeutics Inc
10 Apr 24
Departure of Directors or Certain Officers
4:15pm
, Arcutis is well positioned to achieve its patient-centric mission of advancing innovation in dermatology.” Mr. Topper joins Arcutis from Inmagene
8-K
EX-99.1
ARQT
Arcutis Biotherapeutics Inc
27 Feb 24
Arcutis Announces Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update
7:44am
, seek to address unmet patient needs across multiple dermatology indications, and position Arcutis to accomplish our patient-centric mission
8-K
EX-99.1
ARQT
Arcutis Biotherapeutics Inc
5 May 22
Arcutis Announces First Quarter 2022 Financial Results and Provides Business Update
4:04pm
company and our mission to elevate the standard of care for people suffering from inflammatory skin diseases. We have four transformational catalysts
8-K
EX-99.1
0ffdjyh
22 Feb 22
Arcutis Announces Fourth Quarter and Full Year 2021 Financial Results and Provides Business Update
4:03pm
8-K
EX-99.1
p2ykrpz
23 Dec 21
Arcutis Biotherapeutics Secures $225 Million in Non-Dilutive Debt Financing from SLR Capital Partners
8:04am
8-K
EX-99.1
cydl 9619hn1qte6hhsy
16 Feb 21
Arcutis Announces Fourth Quarter and Full Year 2020 Financial Results and Provides Business Update
4:18pm
8-K
EX-99.1
vx2 gq6p6sndut8
13 May 20
Arcutis Announces First Quarter 2020 Financial Results and Provides Business Update
4:36pm
- Prev
- 1
- Next